Washington, D.C. (March 17, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the introduction today by Senators Alexander and Murray of the FDA and NIH Workforce Authorities Modernization Act:
“This legislation would enhance the FDA’s ability to recruit, hire and retain world-class scientific and technical experts by providing it with common sense hiring authorities and tools. Improvements in human resources management and capability are essential if the FDA is to ensure that safe and effective new medicines, which are being developed with increasingly complex science, reach patients as efficiently and quickly as possible. We thank Senators Alexander and Murray for their leadership on this issue and for introducing this important legislation.”
Upcoming BIO Events
BIO International Convention |
|
13th Annual BIO Asia International Conference | BIO-Europe Spring |
###
About BIO
BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org.